Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1595888 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Derivatives in TARS

reported options exposure · as of Jun 30, 2026
CallValue
$11,964,894
CallShares
190,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in TARS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,964,894 190,100
2026-03-31 $13,468,800 192,000
2025-12-31 $15,090,484 184,300
2025-12-31 $1,677,393 20,486
2025-09-30 $3,602,646 60,620
2025-03-31 $537,124 10,456
2024-12-31 $1,650,026 29,800
2024-12-31 $3,170,264 57,256
2024-12-31 $14,761,642 266,600
2024-09-30 $907,138 27,581
2024-09-30 $1,371,513 41,700
2024-06-30 $2,143,061 78,847
2024-03-31 $1,391,295 38,275
2023-12-31 $387,908 19,156
2023-09-30 $689,707 38,813